COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery (EPIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00355563
Recruitment Status : Completed
First Posted : July 24, 2006
Last Update Posted : January 9, 2009
Information provided by:
Cardica, Inc

Brief Summary:
The study has been designed to comparatively evaluate the safety and effectiveness of the PAS-Port Proximal Anastomosis System and conventional suturing techniques for creation of the connection between graft veins and the aorta in patients undergoing coronary artery bypass graft surgery for treatment of coronary artery disease. Patients in the study will have a coronary angiogram approximately 9 months following surgery to determine the patency of vein grafts created using either the automated PAS-Port or hand sewn methods. Safety will be evaluated by documenting the occurence of adverse clinical events and evealuating possible association with either method.

Condition or disease Intervention/treatment Phase
Coronary Artery Disease Device: PAS-Port Automated Proximal Anastomosis System Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 220 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Use of the PAS-Port Proximal Anastomosis System for Creation of Aorto-Venous Proximal Anastomoses in Coronary Bypass Surgery
Study Start Date : June 2006
Actual Primary Completion Date : December 2007
Actual Study Completion Date : April 2008

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Effectiveness: Graft Patency at 9 months post-operatively
  2. Safety: Peri-and Post-operative MACE and SAE

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No


Inclusion Criteria:

  • Able to give informed consent, able to understand the intent and clinical meaning of the study as well as its implications. Patient is legally competent.
  • Assessment that the patient is willing and able to have follow-up visits and examinations
  • Age greater than or equal to 50 years and less than 85 years
  • Ejection fraction of >30%
  • Can tolerate radiographic contrast media
  • Requires non-emergent coronary artery bypass with at least two vein bypass grafts intended
  • Coronary artery targets intended for bypass index grafts must have >70% native stenosis
  • Life expectancy >1 year

Exclusion Criteria:

  • Patient is participating in other clinical trials that would conflict with this protocol
  • Unable to meet study requirements (travel, general health)
  • Pregnancy
  • Previous cardiac surgery
  • Requiring preoperative use of an intraaortic balloon pump
  • Congestive heart failure / NYHA Class IV
  • History of thromboembolic disease requiring ongoing anticoagulation therapy or the presence of a bleeding disorder
  • Acute or chronic dialysis
  • Creatinine of greater than 200 µmol/L (2.3 mg/dL) in the last 30 days
  • Documented acute or suspected systemic infection
  • Need for ongoing immunosuppressive therapy
  • Recent (less than 2 weeks) history of cerebrovascular accident
  • Aspirin allergy or other contraindications to aspirin use


Inclusion Criteria:

  • Patient is hemodynamically stable
  • Open chest reassessment of the revascularization strategy confirms that two vein bypass grafts are still intended
  • Target vessel wall properties that are suitable for performing both a hand-sewn and a PAS-Port anastomosis
  • Target vessel is greater than 1.8 mm in diameter at sites where anastomoses are planned
  • Target vessel at sites where anastomoses will be placed are free from severe calcifications or severe atheromas
  • The length of the vein graft(s) is adequate for both of the planned index graft revascularization strategies
  • Vein outside diameter and double wall thickness are between 4 and 6 mm(inclusive) and less than or equal to 1.4 mm, respectively, at the graft site intended for the PAS-Port proximal anastomosis
  • The vein(s) is of suitable quality to be used as a bypass graft conduit

Exclusion Criteria:

-Any of the Intra-operative Inclusion Criteria not met

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00355563

Layout table for location information
United States, New Jersey
St. Michael's Medical Center
Newark, New Jersey, United States, 07102
Sponsors and Collaborators
Cardica, Inc
Layout table for investigator information
Principal Investigator: John Puskas, M.D. Emory University
Layout table for additonal information
Responsible Party: Ric Ruedy, Vice President, RA/CA/QA, Cardica, Inc. Identifier: NCT00355563    
Other Study ID Numbers: IP2005-07
First Posted: July 24, 2006    Key Record Dates
Last Update Posted: January 9, 2009
Last Verified: January 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronary Artery Disease
Coronary Disease
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases